Source: Cytotherapy. Unidade: FM
Subjects: LINFÓCITOS T, ZIKA VÍRUS, CORDÃO UMBILICAL, IMUNOTERAPIA, TESTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HANAJIRI, Ryo et al. Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic. Cytotherapy, v. 21, n. 8, p. 840-855, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jcyt.2019.06.008. Acesso em: 06 out. 2024.APA
Hanajiri, R., Sani, G. M., Hanley, P. J., Silveira, C. G., Kallás, E. G., Keller, M. D., & Bollard, C. M. (2019). Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic. Cytotherapy, 21( 8), 840-855. doi:10.1016/j.jcyt.2019.06.008NLM
Hanajiri R, Sani GM, Hanley PJ, Silveira CG, Kallás EG, Keller MD, Bollard CM. Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic [Internet]. Cytotherapy. 2019 ; 21( 8): 840-855.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.jcyt.2019.06.008Vancouver
Hanajiri R, Sani GM, Hanley PJ, Silveira CG, Kallás EG, Keller MD, Bollard CM. Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic [Internet]. Cytotherapy. 2019 ; 21( 8): 840-855.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.jcyt.2019.06.008